Vaso-Occlusive Crisis clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
Sorry, in progress, not accepting new patients
This study is an open-label study to evaluate the safety of long-term administration of inclacumab in participants with sickle cell disease (SCD). Participants in this study will have completed a prior study of inclacumab.
at UC Irvine UCSF